Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.75.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.75.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.75.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBJ.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBJ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.56.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.56.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.56.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.56.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.13.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used